Skip to main content
. 2020 Jul 22;17(15):5279. doi: 10.3390/ijerph17155279

Table 3.

Estimated PM2.5 reduction levels and avoided mortality due to PM2.5 exposure in January to April of 2020 compared to same month each year from 2016 to 2019.

Model 1 (a) Model 2 (b) Model 3 (c) Model 4 (d)
Reduction of PM2.5 by comparing 2016–2019 and 2020 (μg/m3) −5.6 (−9.0, −2.3) −4.1 (−7.2, −0.9) −15.1 (−27.1, −3.2) −11.2 (−14.3, −8.2)
Avoided cause-specific deaths
Estimation using RRs from MCC study
 Non-accidental mortality 51.3 (44.6, 58.1) 37.6 (32.6, 42.5) 137.9 (119.8, 156) 102.5 (89.0, 115.9)
 Cardiovascular disease mortality 9.6 (7.8, 11.5) 7 (5.7, 8.4) 25.7 (21.0, 30.8) 19.1 (15.6, 22.9)
 Respiratory disease mortality 6.5 (4.6, 8.3) 4.7 (3.4, 6.1) 17.3 (12.5, 22.2) 12.9 (9.2, 16.5)
Estimation using RRs from Seoul City study
 Non-accidental mortality 25 (0.8, 49.8) 18.3 (0.6, 36.5) 67.2 (2.0, 133.9) 49.9 (1.5, 99.5)
 Cardiovascular disease mortality 13.2 (2.1, 24.3) 9.7 (1.5, 17.8) 35.4 (5.6, 65.2) 26.3 (4.2, 48.5)
 Respiratory disease mortality 15.3 (4.8, 25.8) 11.2 (3.5, 18.9) 41 (12.9, 68.6) 30.5 (9.6, 51.2)

(a) Model 1 estimated by simple comparison of mean value, (b) Model 2 adjusting for daily average temperature, relative humidity, and wind speed, (c) Model 3 adjusting for daily average temperature, relative humidity, wind speed, years (in continuous variable), and months (as categorical variable), (d) Model 4 adjusting for daily average temperature, relative humidity, and wind speed and considered the effect of particulate filtering respirator.